Search
Search Results
-
Evaluating the Consistency of Patient Preference Estimates: Systematic Variation in Survival—Adverse Event Trade-Offs in Patients with Cancer or Cardiovascular Disease
BackgroundThe increased use of patient preference data in healthcare decision making has raised concerns about the reliability and consistency of the...
-
Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
BackgroundDigoxin immune fab products, DigiBind and DigiFab, are antidotes for the treatment of patients with life-threatening or potentially...
-
Is it a complication or a consequence - a new perspective on adverse outcomes in Interventional Radiology
The aim of the article is to introduce a new term in post-procedural events related to the procedure itself. All the Societies and Councils report...
-
The relationship between patient safety culture and adverse events in Iranian hospitals: a survey among 360 nurses
BackgroundAdverse events have become a global problem and are an important indicator of patient safety. Patient safety culture is essential in...
-
Geriatric Nutritional Risk Index is associated with adverse outcomes in patients with hypertension: the Fukushima Cohort study
Malnutrition is reportedly associated with adverse clinical outcomes in various populations. However, associations between nutritional status and...
-
Continuing the conversation: a cross-sectional study about the effects of work-related adverse events on the mental health of Dutch (resident) obstetrician-gynaecologists (ObGyns)
BackgroundObstetrician - Gynaecologists (ObGyns) frequently face work-related adverse events such as severe obstetric complications and maternal or...
-
Adverse events in spine surgery: a prospective analysis at a large tertiary center in Germany
Study designProspective study
ObjectivesThe occurrence of adverse events (AEs) during surgery is a major cause of increased economic costs,...
-
Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System
IntroductionThrough 2018, three calcitonin gene-related peptide pathway–targeted monoclonal antibodies (CGRP mAbs) had received US Food and Drug...
-
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation
This study investigates the interaction between endothelial activation, indirectly measured using EASIX, and the probability of presenting cardiac...
-
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202
Ibrutinib has superior progression-free survival compared with bendamustine plus rituximab (BR) in older CLL patients, however, differences in...
-
A retrospective analysis of adverse events reported by Tunisian intensive care units’ professionals
IntroductionAdverse events (AEs) that occur in hospitals remain a challenge worldwide, and especially in intensive care units (ICUs) where they are...
-
A premature luteinizing hormone surge without elevated progesterone levels has no adverse effect on cumulative live birth rate in patient undergoing a flexible GnRH antagonist protocol: a retrospective study
BackgroundA premature luteinizing hormone (LH) surge refers to an endogenous LH peak that occurs before follicle maturation or human chorionic...
-
Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
BackgroundPharmacokinetics and pharmacodynamics of drugs in elderly individuals differ from those in younger adults; thus, adverse drug events (ADEs)...
-
Adverse event reporting in head and neck transoral robotic surgery: a MAUDE database study
Transoral robotic surgery (TORS) using the da Vinci Surgical system was approved by the US Food and Drug Administration in 2009. Currently, most...
-
Develo** an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data
IntroductionTime- and resource-demanding activities related to processing individual case safety reports (ICSRs) include manual procedures to...
-
Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare system
BackgroundAntineoplastic monoclonal antibodies (mAbs), such as trastuzumab, bevacizumab, and pertuzumab have been the mainstay of therapy in cancer...
-
Adverse events of pancreatic extracorporeal shock wave lithotripsy: a literature review
Pancreatic stones are the result of pathophysiologic changes in chronic pancreatitis with an incidence of more than 90%. At present, pancreatic...
-
Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data
BackgroundFurther understanding of adverse clinical event rates in patients with chronic kidney disease (CKD) is required for improved quality of...
-
Impact of renal function on adverse bleeding events associated with dual antiplatelet therapy in patients with acute coronary syndrome
It is believed, but not well established, that renal dysfunction increases the risk of adverse bleeding events associated with dual antiplatelet...
-
Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database
Background Rivaroxaban, apixaban and dabigatran are non-vitamin K antagonist oral anticoagulants (NOACs) that are widely used for treatment or...
